Financials data is unavailable for this security.
Cash flow in EURView more
In 2023, Herantis Pharma Oyj increased its cash reserves by 9.28%, or 467.24k. Cash Flow from Financing totalled 4.50m or -- of revenues. In addition the company used 4.64m for operations while cash from investing totalled 607.08k.
Cash flow per share | 0.1103 |
---|---|
Price/Cash flow per share | 14.53 |
Book value per share | 0.1012 |
---|---|
Tangible book value per share | 0.1012 |
More ▼
Balance sheet in EURView more
Current ratio | 2.30 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0147 |
---|---|
Total debt/total capital | 0.0145 |
More ▼